Nitric oxide-induced reduction of lung cell and whole lung thioredoxin expression is regulated by NF-κB

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 277, Issue 4 21-4, 1999, Pages

  Zhang, Jianliang ^a   Velsor, Leonard W ^c   Patel, Jawaharlal M ^a,b,d   Postlethwait, Edward M ^c   Block, Edward R ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Research Service   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene regulation; Lung endothelium; Mouse lung; Nuclear factor B; Transcription factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NITRIC OXIDE; THIOREDOXIN;

ANIMAL CELL; ARTICLE; IMMUNOBLOTTING; LUNG ENDOTHELIUM; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SWINE;

EID: 0032760015     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.277.4.l787     Document Type: Article

References (44)

1. Abate, C., L. Patel, F. J. Rauscher, and T. Curran. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249: 1157-1161, 1990.
2. - donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch. Biochem. Biophys. 318: 279-285, 1995.
3. 1) in Epstein-Barr virus-immortalized B cell lines. J. Biol. Chem. 270: 31244-31248, 1995.
4. Baldwin, A. S. The NFκB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-681, 1996.
5. Barnes, P. J., and M. G. Belvisi. Nitric oxide and lung disease. Thorax 48: 1034-1043, 1993.
6. Berisha, H. I., H. Pakbaz, A. Absood, and S. I. Said. Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc. Natl. Acad. Sci. USA 91: 7445-7449, 1994.
7. Bigatello, L. M., W. E. Hurford, R. M. Kacmarek, J. D. Roberts, and W. M. Zapol. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 80: 761-770, 1994.
8. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein ultilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
9. Bredt, D. S., and S. H. Snyder. Iso ation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA 87: 682-690, 1990.
10. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. Mutual regulation of the transcript onal activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90: 2532-2536, 1995.
11. Chiao, P. J., S. Miyamoto, and I. M. Verma. Autoregulation of IκB-α activity. Proc. Natl. Acad. Sci. USA 91: 28-32, 1994.
12. Colasanti, M., T. Persichini, M. Menegazzi, S. Mariotto, E. Giordano, C. M. Caldarera, V. Sogos, G. M. Lauro, and H. Suzuki. Induction of nitric oxide synthase mRNA expression. Suppression by exogenous nitric oxide. J. Biol. Chem. 270: 26731-26733, 1995.
13. Curran, R. D., F. K. Ferrari, P. H. Kispert, J. Stadler, D. J. Stuehr, R. J. Simmons, and T. R. Billiar. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5: 2085-2092, 1991.
14. Davies, M. G., G. J. Fulton, and P. O. Hagen. Clinical biology of nitric oxide. Br. J. Surg. 82: 1598-1610, 1995.
15. Didonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. A cytokine-responsive IκE kinase that activates the transcription factor NF-κB. Nature 388: 458-554, 1997.
16. Gerlach, H., D. Pappert, K. Lewandowski, R. Rossaint, and K. J. Falke. Long-term inhalation with elevated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med. 19: 443-449, 1993.
17. Hayashi, T., Y. Ueno, and T. Okamoto. Oxidoreductive regulation of nuclear factor-κB. Involvement of a cellular reducing catalyst thioredoxin. J. Biol. Chem. 268: 11380-11388, 1993.
18. Isaacson, T. C., V. Hampl, E. K. Weir, D. P. Nelson, and S. L. Archer. Increased endothelium-de rived NO in hypertensive pulmonary circulation of chronically hypoxic rats. J. Appl. Physiol. 76: 933-940, 1994.
19. Lee, J. J., and N. A. Costlow. A molecular titration assay to measure transcript prevalence levels. Methods Enzymol. 152: 633-648, 1987.
20. Kaghad, M., F. Dessarps, H. Jacquemin-Sablon, D. Caput, D. Fradelizi, and E. E. Wollman. Gencmic cloning of human thioredoxin-encoding gene: mapping of tie transcription start point and analysis of the promoter. Gene 140: 273-278, 1994.
21. Kim, Y. M., S. Kyonghee, S. J. Hong, A. Green, J. J. Chen, E. Tzeng, C. Hierholzer, and T. R. Billiar. Inhibition of protein synthesis with cytostatic activity: nitric oxide induces phosphorylation of initiation factor eIF-2aα. Mol. Med. 4: 179-190, 1998.
22. Kolpakov, V., D. Gordon, and T. Kulik. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ. Res. 76: 305-309, 1995.
23. Lin, Y. C., K. Brown, and U. Siebenlist. Activation of NF-κB requires proteolysis of the inhibitor IκB-α: signal-induced phosphorylation of IκB-α alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92: 552-556, 1995.
24. Ma, X. L., B. L. Lopez, T. A. Christopher, D. S. Birenbaum, and J. Vinten-Johansen. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H2045-H2051, 1996.
25. Marsden, P. A., H. H. Heng, S. W. Scherer, R. J. Stewart, A. V. Hall, X. M. Shi, L. C. Tsui, and K. T. Schappert. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268: 17478-17488, 1993.
26. Nadaud, S., A. Bonnardeaux, M. Lathrop, and F. Soubrier. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem. Biophys. Res. Commun. 198: 1027-1033, 1994.
27. Oka, M., M. Ohnishi, H. Takahashi, S. Soma, K. Hasunuma, K. Sato, and S. Kira. Altered vasoreactivity in lungs isolated from rats exposed to nitric oxide gas. Am. J. Physiol. 271 (Lung Cell. Mol. Physiol. 15): L419-L424, 1996.
28. Park, S. K., H. I. Lin, and S. Murphy. Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA. Biochem. J. 322: 609-613, 1997.
29. Patel, J. M., A. J. Abeles, and E. R. Block. Nitric oxide exposure and sulfhydryl modulation alter L-arginine transport in cultured pulmonary artery endothelial cells. Free Radic. Biol. Med. 20: 629-637, 1996.
30. Patel, J. M., and E. R. Block. Acrolein-induced injury to cultured pulmonary artery endothelial cells. Toxicol. Appl. Pharmacol. 122: 46-53, 1993.
31. Patel, J. M., and E. R. Block. Sulfhydryl-disulfide modulation and the role of disulfide oxidoreductases in regulation of the catalytic activity of nitric oxide synthase in pulmonary artery endothelial cells. Am. J. Respir. Cell Mol. Biol. 13: 352-359, 1995.
32. Patel, J. M., J. L. Zhang, and E. R. Block. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of thioredoxin in regulation of catalytic activity. Am. J. Respir. Cell Mol. Biol. 15: 410-419, 1996.
33. Peng, H. B., P. Libby, and J. K. Liao. Induction and stabilization of IκB-α by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem. 270: 14214-14219, 1995.
34. Pepke-Zaba, J., T. W. Higenbottam, A. T. Dinh-Xuan, D. Stone, and J. Wallwork. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 338: 1173-1174, 1991.
35. Powis, G., M. Briehl, and J. Oblong. Redox signalling and the control of cell growth and death. Pharmacol. Ther. 68: 149-173, 1995.
36. Roberts, J. D., J. R. Fineman, F. C. Morin III, P. W. Shaul, S. Rimar, M. D. Schreiber, R. A. Polin, M. S. Zwass, M. M. Zayek, I. Gross, M. A. Heymann, and W. M. Zapol. Inhaled nitric oxide and persistent pulmonary hyptertension of the newborn. N. Engl. J. Med. 336: 605-610, 1997.
37. Sheffler, L. A., D. A. Wink, G. Melillo, and G. W. Cox. Exogenous nitric oxide regulates IFN-γ plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages. J. Immunol. 155: 886-894, 1995.
38. Siebenlist, U., G. Franzoso, and K. Brown. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455, 1994.
39. Tanaka, H., Y. Chiba, M. Sasaki, S. Matsukawa, and R. Muraoka. Relationship between flushing pressure and nitric oxide production in preserved lungs. Transplantation 65: 460-464, 1998.
40. Thanos, D., and T. Maniatis. NF-κB: a lesson in family values. Cell 80: 529-532, 1995.
41. Winer, B. J. Statistical Principles in Experimental Design. New York: McGraw Hill, 1971, p. 210-219.
42. Zhang, J. L., Y. D. Li, J. M. Patel, and E. R. Block. Thioredoxin overexpression prevents NO-induced reduction of NO synthase activity in lung endothelial cells. Am. J. Physiol. 275 (Lung Cell. Mol. Physiol. 19): L288-L293, 1998.
43. Zhang, J. L., J. M. Patel, Y. D. Li, and E. R. Block. Proinflammatory cytokines downregulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells. Res. Commun. Mol. Pathol. Pharmacol. 96: 71-78, 1997.
44. Zinn, K., D. DiMaio, and T. Maniatis. Identification of two distinct regulatory regions adjacent to the human ß-interferon gene. Cell 34: 865-879, 1993.